CN1897960A - 用于保护、恢复和增强效应细胞、组织和器官具有延迟的治疗窗口的组织保护性细胞因子 - Google Patents

用于保护、恢复和增强效应细胞、组织和器官具有延迟的治疗窗口的组织保护性细胞因子 Download PDF

Info

Publication number
CN1897960A
CN1897960A CNA200480038280XA CN200480038280A CN1897960A CN 1897960 A CN1897960 A CN 1897960A CN A200480038280X A CNA200480038280X A CN A200480038280XA CN 200480038280 A CN200480038280 A CN 200480038280A CN 1897960 A CN1897960 A CN 1897960A
Authority
CN
China
Prior art keywords
cell
erythropoietin
tissue
pharmaceutical composition
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200480038280XA
Other languages
English (en)
Chinese (zh)
Inventor
A·切拉米
M·布赖恩斯
T·科尔曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Warren Kenneth S Institute Inc
Original Assignee
H Lundbeck AS
Warren Kenneth S Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS, Warren Kenneth S Institute Inc filed Critical H Lundbeck AS
Publication of CN1897960A publication Critical patent/CN1897960A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA200480038280XA 2004-05-20 2004-05-20 用于保护、恢复和增强效应细胞、组织和器官具有延迟的治疗窗口的组织保护性细胞因子 Pending CN1897960A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/015863 WO2005117927A2 (fr) 2004-05-20 2004-05-20 Cytokines protegeant les tissus pour la protection, la restauration et l'augmentation des cellules receptives, des tissus et des organes par une fenetre therapeutique etendue

Publications (1)

Publication Number Publication Date
CN1897960A true CN1897960A (zh) 2007-01-17

Family

ID=35463339

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200480038280XA Pending CN1897960A (zh) 2004-05-20 2004-05-20 用于保护、恢复和增强效应细胞、组织和器官具有延迟的治疗窗口的组织保护性细胞因子

Country Status (7)

Country Link
CN (1) CN1897960A (fr)
AU (1) AU2004319797A1 (fr)
BR (1) BRPI0412869A (fr)
IL (1) IL172036A0 (fr)
IS (1) IS8222A (fr)
NO (1) NO20062506L (fr)
WO (1) WO2005117927A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
WO2019072411A1 (fr) * 2017-10-10 2019-04-18 Augustinus Bader Application d'érythropoïétine (epo) dans une thérapie de lésion de la moelle épinière (lme)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
EP1633383A4 (fr) * 2003-03-27 2008-05-21 Janssen Pharmaceutica Nv Utilisation de l'erythropoietine pour un retablissement a la suite d'un accident ischemique cerebral

Also Published As

Publication number Publication date
AU2004319797A1 (en) 2006-01-12
NO20062506L (no) 2006-05-31
AU2004319797A8 (en) 2008-12-11
BRPI0412869A (pt) 2006-10-03
WO2005117927A3 (fr) 2006-05-11
WO2005117927A2 (fr) 2005-12-15
IS8222A (is) 2006-01-10
IL172036A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
CN1946416A (zh) 用于保护、恢复和增强效应细胞、组织和器官具有延迟的治疗窗口的组织保护性细胞因子
US20200338171A1 (en) Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN1607957A (zh) 外周给药的红细胞生成素对应激组织功能的调制
CN1261158C (zh) 生长激素在制备用于诱导神经保护作用的药剂中的应用
CN1582146A (zh) 用非多肽环－磷酸腺苷水平调节剂诱导排卵的方法
KR20190116416A (ko) 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법
US20100113347A1 (en) Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes
JP2011256178A (ja) 非閉経女性における卵胞貯蔵を調節するのに意図した医薬を製造するのにソマトスタチン又はその同族体の１つの使用
CN1331698A (zh) 含有人参皂甙Rb1的脑细胞或神经细胞保护剂
CN1723034A (zh) 治疗糖尿病的组合物和方法
JPH08511541A (ja) Ｄｅｓ−ｔｙｒダイノルフィンおよび類似体に関する抗炎症組成物並びに方法
JP2002502369A (ja) 胃腸管上部の機能を強化する方法
ES2547233T3 (es) Composición para su uso en el tratamiento de la esterilidad
ES2507569T3 (es) Agente profiláctico o terapéutico contra enfermedades oculares acompañadas de un trastorno del nervio óptico
KR20140091522A (ko) 심부전증 또는 신경 손상을 치료하기 위한 인돌릴 및 인돌리닐 하이드록사메이트의 용도
CN1897960A (zh) 用于保护、恢复和增强效应细胞、组织和器官具有延迟的治疗窗口的组织保护性细胞因子
JP3415643B2 (ja) 筋ジストロフィー症治療薬
CN106794178A (zh) 去势治疗相关症状的治疗
CN111265652B (zh) 多肽在制备治疗缺血性脑血管疾病的药物中的应用
CN1889961A (zh) 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物
KR102475179B1 (ko) 출혈성 뇌졸중 치료용 약물 제조에서의 화합물의 용도
US5691313A (en) Methods of treating impotency with ciliary neurotrophic factor
EP2816056A1 (fr) Agent améliorant en cas de dysfonctionnement de la barrière hémato-encéphalique
CN1108138A (zh) 缓激肽拮抗剂在制备治疗病毒性疾病的药物用途
KR20060084844A (ko) 확장된 치료 윈도우를 갖는, 반응성 세포, 조직 및 기관의보호, 회복 및 개선을 위한 조직 보호성 사이토카인

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1103014

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1103014

Country of ref document: HK